Periodic Reporting for period 3 - Glue2Degrade (Therapeutic hijacking of E3 Ligases)

To this day, the innovation of new therapeutic concepts is predominantly based on small molecules that bind to the active site of enzymes or transporters to inhibit their underlying biochemical activity. In brief: the community is looking for inhibitors. Because of this...